In this study, we designed FOLR1-CAR composed of anti-FOLR1 scFv, CD28 and CD3ζ and evaluated the antitumor activity of CAR-mediated T cells against FOLR1 positive and negative gastric cancer cells. Here, FOLR1 is linked to gastric cancer.